Literature DB >> 10670752

Serum leptin levels and bioelectrical impedance assessment of body composition in patients with Graves' disease and hypothyroidism.

M Miyakawa1, T Tsushima, H Murakami, O Isozaki, K Takano.   

Abstract

We investigated whether thyroid status modulates serum leptin concentrations and body composition as determined by bioelectric impedance analysis (BIA). The percent body fat mass (%FM) in male Graves' disease was significantly lower than that in age- and sex- matched normal subjects, at the levels of 11.4+/-6.4% (mean+/-SD) vs 19.9+/-9.2% for men (n=12, P<0.05) but not for women (22.6+/-7.6% vs 24.9+/-13.1%, n=28). In contrast, in female hypothyroidism (n=11) %FM was significantly higher than that in normal subjects (32.9+/-11.5%, P<0.01). Among other body composition parameters, the percentage of body water (%BW), and lean body mass (LBM) were significantly lower in hypothyroid patients, and the ECM (extracellular mass)/BCM (body cell mass) ratio was significantly (P<0.0001) increased in Graves' disease which was the result of marked depletion of BCM with concomitant expansion of ECM. The serum leptin levels were significantly decreased in male Graves' patients (2.3+/-0.7 ng/ml, P<0.05), whereas in female Graves' patients (8.8+/-5.9 ng/ml) and patients with hypothyroidism (9.5+/-7.6 ng/ml), the levels were not different from those of normal controls matched for BMI or %FM. There was a positive correlation between serum leptin levels and %FM in female Graves' patients (r=0.635, P=0.001) and in hypothyroid patients (r=0.801, P=0.014) but not in male Graves patients. There was no significant relationship between serum leptin levels and thyroid hormones, TRAb, or TSAb. In euthyroid obese subjects there was a positive relationship between serum leptin levels and serum TSH levels (r=0.37, P<0.01). These results suggest that hyperthyroidism is characterized by the decreased fat mass and serum leptin levels in men, but female patients appear to be resistant to the effect of thyroid hormones. Together with previous reports, thyroid status has a minor role in the regulation of serum leptin levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10670752     DOI: 10.1507/endocrj.46.665

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

1.  Treatment of paediatric hyperthyroidism but not hypothyroidism has a significant effect on weight.

Authors:  Melissa K Crocker; Paul Kaplowitz
Journal:  Clin Endocrinol (Oxf)       Date:  2010-12       Impact factor: 3.478

2.  Redistribution of body composition in patients with Graves' disease after iodine-131 treatment.

Authors:  L-J Xie; H-J Zhou; J-F Li; F Zhang; F-W Zeng; L-P Qin; Y Chen; H-J Yuan; M-H Cheng
Journal:  Eur J Clin Nutr       Date:  2014-10-29       Impact factor: 4.016

3.  Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion.

Authors:  P Cettour-Rose; C Theander-Carrillo; C Asensio; M Klein; T J Visser; A G Burger; C A Meier; F Rohner-Jeanrenaud
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

4.  Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery.

Authors:  S Alagna; M L Cossu; A Masala; M M Atzeni; M Ruggiu; F M Satta; E Fais; P P Rovasio; G Noya
Journal:  Eat Weight Disord       Date:  2003-06       Impact factor: 4.652

5.  Alterations of Serum Leptin Levels in Patients with Autoimmune Thyroid Disorders.

Authors:  Niloofar Keikhaei; Zahra Heidari
Journal:  Med J Islam Repub Iran       Date:  2021-12-14

6.  Correction of hypothyroidism seems to have no effect on body fat.

Authors:  Okan Bakiner; Emre Bozkirli; Emine Duygu Ersozlu Bozkirli; Kursat Ozsahin
Journal:  Int J Endocrinol       Date:  2013-09-17       Impact factor: 3.257

7.  Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism.

Authors:  Cheng Han; Xinghai Xia; Aihua Liu; Xiaowen Zhang; Mi Zhou; Chuhui Xiong; Xin Liu; Jie Sun; Xiaoguang Shi; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2016-04-26       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.